ema prac naion semaglutide Novo Nordisk refutes link between Wegovy and eye disease EMA's PRAC starts semaglutide review

Food and Drug Administration announced a new green list import alert aimed at stopping illegal and potentially dangerous GLP-1 drug ingredients from entering the country

Future Outlook Over the next five years, the India GLP-1 Receptor Agonist Market is projected to undergo significant growth fueled by the continuous rise in diabetes cases, enhanced awareness about chronic disease management, and ongoing innovations in drug formulations

Always great service and advice. David S Very professional personnal and knowledgeable doctor. Alex S Dr Gadhavi and the staff are very professional and welcoming. Samit V Took care of me as soon as I walked in and the receptionists were all very friendly. Phaedra B

Cell numbers were determined by plating for colony counts